Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

ProQR Therapeutics (PRQR) Depreciation Expense (2021)

Historic Depreciation Expense for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to $763145.0.

  • ProQR Therapeutics' Depreciation Expense rose 2085.17% to $763145.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $2.7 million, marking a year-over-year decrease of 393.38%. This contributed to the annual value of $3.0 million for FY2024, which is 993.17% up from last year.
  • As of Q4 2022, ProQR Therapeutics' Depreciation Expense stood at $763145.0, which was up 2085.17% from $617063.9 recorded in Q3 2022.
  • ProQR Therapeutics' Depreciation Expense's 5-year high stood at $763145.0 during Q4 2022, with a 5-year trough of $617063.9 in Q3 2022.